Breaking News

Sartorius Expands Capacity

Sartorius Stedim Systems GmbH, a subsidiary of Sartorius Stedim Biotech (SSB), is expanding its capacity and optimizing its production operations by combining its work and production areas.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sartorius Stedim Systems GmbH, a subsidiary of Sartorius Stedim Biotech (SSB), is expanding its capacity and optimizing its production operations by combining its work and production areas. A new plant will be built in the industrial zone in Guxhagen, Germany. The new building will be approximately 93,000 sq. ft., providing 50% more office and production space. The cost of the project will be approximately 14 million euros. Construction is scheduled to begin in the spring of 2011 with a relocati...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters